Back to search

Article

Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers

2021-01-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Diverse vaccination outcomes and protection levels among different populations pose a serious challenge to the development of an effective malaria vaccine. Co-infections are among many factors associated with immune dysfunction and sub-optimal vaccination outcomes. Chronic, asymptomatic viral infections can contribute to the modulation of vaccine efficacy throug...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a8a3f68b-2a60-56fc-80a1-51fcc206becb
DOI
10.21203/rs.3.rs-64109/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteersDOI 10.21203/rs.3.rs-64109/v2
Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future DirectionsSemantic proximity
Immune tolerance to asymptomatic submicroscopic Plasmodium falciparum infections in adults living in malaria endemic areasSemantic proximity
Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in GhanaSemantic proximity
Strains used in whole organism <i>Plasmodium falciparum</i> vaccine trials differ in genome structure, sequence, and immunogenic potentialSemantic proximity
Heterogeneity of the human immune response to malaria infection and vaccination driven by latent cytomegalovirus infectionSemantic proximity
Genotypic analysis of RTS,S/AS01E malaria vaccine efficacy against parasite infection as a function of dosage regimen and baseline malaria infection status in children aged 5-17 months in Ghana and Kenya: a longitudinal phase 2b randomised controlled trial.Semantic proximity
Distinct immune responses associated with vaccination status and protection outcomes after malaria challengeSemantic proximity
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectorsSemantic proximity
A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1Semantic proximity
The landscape of paediatric infectious disease exposure in a rural sub-Saharan Africa setting in Kilifi, Kenya: longitudinal serological analysis over two decades and priorities for future vaccine developmentSemantic proximity
Distinct immune responses associated with vaccination status and protection outcomes after malaria challengeSemantic proximity
Human pegivirus (HPgV) infection in sub-Saharan Africa-A call for a renewed research agenda.Semantic proximity
Select a neighboring publication to make it the new centre.